US EditionPublished • loading... • Updated
CAR T Cells As Novel Therapeutic Strategy for Multiple Sclerosis and Other Neuroimmune Disorders
Summary by Stemwell Science News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
CAR T Cells As Novel Therapeutic Strategy for Multiple Sclerosis and Other Neuroimmune Disorders
Investigators synthesize the current evidence supporting the use of CAR T-cell therapy in neuroinflammatory diseases and explore its potential to redefine treatment paradigms by shifting from chronic immunosuppression to long-term immune tolerance. [Journal of Neuroinflammation] Abstract
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
